Mutual Prodrugs of 5‐Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Mutual Prodrugs of 5‐Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs ; day:07 ; month:09 ; year:2021 ; extent:1
ChemMedChem ; (07.09.2021) (gesamt 1)
- Urheber
-
Ciaffaglione, Valeria
Modica, Maria N.
Pittalà, Valeria
Romeo, Giuseppe
Salerno, Loredana
Intagliata, Sebastiano
- DOI
-
10.1002/cmdc.202100473
- URN
-
urn:nbn:de:101:1-2021090715133876426495
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ciaffaglione, Valeria
- Modica, Maria N.
- Pittalà, Valeria
- Romeo, Giuseppe
- Salerno, Loredana
- Intagliata, Sebastiano
Ähnliche Objekte (12)
Molecular Basis of Drug Interactions of Methotrexate, Cyclophosphamide and 5-Fluorouracil as Chemotherapeutic Agents in Cancer
Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5‐Fluorouracil and Imidazole‐Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells
Aminoferrocen-basierte, krebsspezifische Prodrugs
Synthese von Entacapon-Prodrugs
Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28
"Prodrugs" glycerolipidiques comme systeme pharmaceutique
Synthese und Untersuchung von Nucleosiddiphosphat Prodrugs
Synthese von acyclischen Phosphonat-Diphosphat-Prodrugs
Therapie des fortgeschrittenen kolorektalen Karzinoms: Ergebnisse der systemischen Folinsäure/5-Fluorouracil- [Folinsäure-Fluorouracil-] und der regionalen 5-Fluorouracil-Therapie [Fluorouracil-Therapie]
Hochdosierte 5-Fluorouracil-Therapie [Fluorouracil-Therapie] bei kolorektelen Tumoren
Molecular Basis of Drug Interactions of Methotrexate, Cyclophosphamide and 5-Fluorouracil as Chemotherapeutic Agents in Cancer
Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5‐Fluorouracil and Imidazole‐Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells
Aminoferrocen-basierte, krebsspezifische Prodrugs
Synthese von Entacapon-Prodrugs
Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28
"Prodrugs" glycerolipidiques comme systeme pharmaceutique
Synthese und Untersuchung von Nucleosiddiphosphat Prodrugs
Synthese von acyclischen Phosphonat-Diphosphat-Prodrugs
Therapie des fortgeschrittenen kolorektalen Karzinoms: Ergebnisse der systemischen Folinsäure/5-Fluorouracil- [Folinsäure-Fluorouracil-] und der regionalen 5-Fluorouracil-Therapie [Fluorouracil-Therapie]
Hochdosierte 5-Fluorouracil-Therapie [Fluorouracil-Therapie] bei kolorektelen Tumoren
Molecular Basis of Drug Interactions of Methotrexate, Cyclophosphamide and 5-Fluorouracil as Chemotherapeutic Agents in Cancer
Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5‐Fluorouracil and Imidazole‐Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells
Aminoferrocen-basierte, krebsspezifische Prodrugs
Synthese von Entacapon-Prodrugs
Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28
"Prodrugs" glycerolipidiques comme systeme pharmaceutique
Synthese und Untersuchung von Nucleosiddiphosphat Prodrugs
Synthese von acyclischen Phosphonat-Diphosphat-Prodrugs
Therapie des fortgeschrittenen kolorektalen Karzinoms: Ergebnisse der systemischen Folinsäure/5-Fluorouracil- [Folinsäure-Fluorouracil-] und der regionalen 5-Fluorouracil-Therapie [Fluorouracil-Therapie]